Pura Vida Investments, LLC

In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 13, 2026), Pura Vida Investments, LLC reported 19 stock positions worth $37.0 million. Its top holding was Alamar Biosciences (ALMR) at 55.4% of the portfolio, followed by Beta Bionics (BBNX, 11.9%) and Establishment Labs (ESTA, 10.4%). Compared with Q1 2026, it opened 2 new positions, added to 2 and reduced 5. The biggest buy was a new position in Alamar Biosciences (ALMR) and the biggest sale Insight Molecular Diagnostic (IMDX, shares −49%).

Most Recent 13F
Q2 2026
Location
NEW YORK, NY
CIK
0001590144
Portfolio Value
$37.0M (Q2 2026)
SEC Filing
0001590144-26-000004 ↗ filed Aug 13, 2026

Holdings Value

0$50.0M$100.0M$150.0M Q1 2024: $146.8M Q1 2024 Q2 2024: $82.7M Q2 2024 Q3 2024: $60.8M Q3 2024 Q4 2024: $18.1M Q4 2024 Q1 2025: $13.7M Q1 2025 Q2 2025: $16.6M Q2 2025 Q3 2025: $16.4M Q3 2025 Q4 2025: $26.8M Q4 2025 Q1 2026: $14.9M Q1 2026 Q2 2026: $37.0M $37.0M Q2 2026

Holdings 19 stocks · $37.0M

ALMR Alamar Biosciences Inc. 55.35% 755,909 $20.5M New
BBNX Beta Bionics Inc. 11.91% 281,164 $4.4M Reduce -0.0%
ESTA Establishment Labs Holdings 10.44% 45,000 $3.9M No change
IMDX Insight Molecular Diagnostic 7.73% 484,845 $2.9M Reduce -48.8%
NVDA Nvidia Corp. 1.24% 2,300 $460K Reduce -8.0%
CAI Caris Life Sciences Inc. 1.23% 25,500 $454K Reduce -71.7%
JPM JPMorgan Chase & Co. 1.19% 1,350 $442K No change
GOOG Alphabet Inc. Class C 1.15% 1,200 $424K Add +0.8%
NTRA Natera Inc. 1.10% 1,500 $407K Reduce -40.0%
ADI Analog Devices Inc. 1.07% 1,000 $397K No change
ASML ASML Holding NV-NY Reg SHS filed as ASML HLDG NV 1.02% 190 $378K No change
MSFT Microsoft Corp. 1.01% 1,000 $373K Add +1.0%
OM Outset Medical Inc. 0.97% 83,333 $360K No change
AAPL Apple Inc. 0.91% 1,165 $337K No change
NSPR Inspiremd Inc. 0.85% 450,517 $315K No change
MGX Metagenomi Therapeutics Inc. 0.85% 264,391 $315K No change
AMZN Amazon.com Inc. 0.71% 1,100 $262K No change
LIN Linde PLC 0.70% 500 $259K No change
KO The Coca-Cola Co. 0.55% 2,500 $203K New

Portfolio Sells Q1 2026 → Q2 2026

IMDX Insight Molecular Diagnostic Reduce -48.8% 7.73% −13.15
CAI Caris Life Sciences Inc. Reduce -71.7% 1.23% −9.58
BBNX Beta Bionics Inc. Reduce -0.0% 11.91% −7.03
NTRA Natera Inc. Reduce -40.0% 1.10% −2.26
NVDA Nvidia Corp. Reduce -8.0% 1.24% −1.69

Portfolio Buys Q1 2026 → Q2 2026

ALMR Alamar Biosciences Inc. New 55.35% +55.35
KO The Coca-Cola Co. New 0.55% +0.55
GOOG Alphabet Inc. Class C Add +0.8% 1.15% −1.15
MSFT Microsoft Corp. Add +1.0% 1.01% −1.45

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 19$37.0MALMR, BBNX, ESTA, IMDX, NVDA
Q1 2026 17$14.9MIMDX, BBNX, ESTA, CAI, NSPR
Q4 2025 18$26.8MBBNX, IMDX, ESTA, CAI, NSPR
Q3 2025 8$16.4MBBNX, IMDX, CAI, ESTA, NSPR
Q2 2025 8$16.6MBBNX, IMDX, CAI, ESTA, OM
Q1 2025 8$13.7MBBNX, IMDX, ESTA, NSPR, KMTS
Q4 2024 9$18.1MESTA, MSOS, LUNG, QTRX, IMDX
Q3 2024 16$60.8MMSOS, ESTA, GKOS, NTRA, ISRG
Q2 2024 25$82.7MESTA, GKOS, ISRG, NTRA, MSOS
Q1 2024 30$146.8MEXAS, ESTA, ISRG, QTRX, LYRA